Frozen-thawed Embryo Transfer in a Natural Cycle: hCG Triggering Versus LH Home Test
Phase 4
Terminated
- Conditions
- Infertility
- Interventions
- Other: Home ovulation test
- Registration Number
- NCT03115320
- Lead Sponsor
- Tampere University Hospital
- Brief Summary
The primary aim of this study is to find out if ovulation triggered with hCG provides any additional benefit in comparison to spontaneous LH surge measured with the LH surge home test when transferring frozen-thawed embryo in a natural cycle.
- Detailed Description
The aim of this study is to find out the best method for the ovulation triggering. We study the live birth rates in the both groups.
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- Female
- Target Recruitment
- 62
Inclusion Criteria
-
- Patient with IVF or ICSI cycle and therefore having frozen-thawed embryos
- Regular menstruation cycle
- Patient's willingness to participate in the study
Exclusion Criteria
-
- Irregular menstrual cycle demanding preparing endometrium with hormones for frozen-thawed embryo
- No frozen embryos after IVF cycle
- Allergy to Pregnyl® or some of its ingredients in the medication or other contraindications due to Pregnyl®
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Home ovulation test Home ovulation test The patients randomized to the LH surge group perform the ovulation home test daily from the urine. Thus, the ovulation in this group is corfimed by the urine test. The day of transferring embryo is depending on the positive ovulation test and the age of the embryo. The day zero day is defined by positive ovulation test. Pregnyl (Human chorionic gonadotropin) Human chorionic gonadotropin In this group, patients have natural cycle in frozen-thawed embryo transfer and the ovulation is confirmed by administration of hCG (Pregnyl® 5000 IU). The day of transferring embryo is depending on the day of administration of hCG and the age of the embryo. The day zero day is defined by ovulation triggered by hCG.
- Primary Outcome Measures
Name Time Method Live birth rate At possible delivery (about 40 weeks) Live birth rate
- Secondary Outcome Measures
Name Time Method Ongoing pregnancy rate After two weeks Ongoing pregnancy rate
Trial Locations
- Locations (1)
Tampere University Hospital
🇫🇮Tampere, Finland